Skip to content

HKPD CELLYAN BIOTECHNOLOGY CO LTD

Follow

ORD SHS CL A (common), issuer CIK 2007702

6 managers (6 13F filers) reported a position in HKPD shares at 2026-06-30, 245,251 shares in all. 3 filers opened a position and 1 filer sold out during the quarter.

Managers
6
13F filers
6
New
3
Added
2
Reduced
0
Sold out
1
Shares held by filers
245,251

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q2 2026

Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
StoneX Group Inc.in group StoneX Group Inc.102,310$52.4K<0.01%+62,91513F-HRTimelineGroup
JANE STREET GROUP, LLCin group JANE STREET GROUP, LLC49,087$18.7K<0.01%new13F-HRTimelineGroup
HRT FINANCIAL LP41,824$15K<0.01%new13F-HRTimeline
XTX Topco Ltdin group XTX Topco Ltd38,930$14.8K<0.01%new13F-HRTimelineGroup
Clear Street Group Inc.in group Clear Street Group Inc.12,019$4.57K<0.01%013F-HRTimelineGroup
UBS Group AGin group UBS Group AG1,081$411<0.01%+97113F-HRTimelineGroup